12-121626888-G-GCCGCCGCCGCAGCGGGGACGGGGAGCCCCCGGGGGCC
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The ENST00000617316.2(ORAI1):c.141_142insCCGCCGCCGCAGCGGGGACGGGGAGCCCCCGGGGGCC(p.Ser48ProfsTer52) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★). Synonymous variant affecting the same amino acid position (i.e. P47P) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
ENST00000617316.2 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ORAI1 | NM_032790.3 | c.144_145insCCGCCGCCGCAGCGGGGACGGGGAGCCCCCGGGGGCC | p.Ser49ProfsTer52 | frameshift_variant | 2/3 | NP_116179.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ORAI1 | ENST00000617316.2 | c.141_142insCCGCCGCCGCAGCGGGGACGGGGAGCCCCCGGGGGCC | p.Ser48ProfsTer52 | frameshift_variant | 2/3 | 1 | ENSP00000482568 | P1 | ||
ORAI1 | ENST00000611718.1 | n.73_74insCCGCCGCCGCAGCGGGGACGGGGAGCCCCCGGGGGCC | non_coding_transcript_exon_variant | 1/2 | 5 | |||||
ORAI1 | ENST00000646827.1 | n.339_340insCCGCCGCCGCAGCGGGGACGGGGAGCCCCCGGGGGCC | non_coding_transcript_exon_variant | 1/2 | ||||||
ORAI1 | ENST00000698901.1 | n.380_381insCCGCCGCCGCAGCGGGGACGGGGAGCCCCCGGGGGCC | non_coding_transcript_exon_variant | 1/2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 34
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Combined immunodeficiency due to ORAI1 deficiency Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 21, 2017 | This sequence change results in a premature translational stop signal in the ORAI1 gene (p.Ser48Glnfs*52). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 254 amino acids (>80%) of the ORAI1 protein. This variant is not present in population databases (ExAC no frequency) and has not been reported in the literature in individuals with an ORAI1-related disease. Loss-of function variants in ORAI1 are known to be causative of autosomal recessive ORAI1 deficiency. Truncating variants downstream of this variant (p.Ala88serfs*25, p.His165Profs*2, p.Arg268*) have been reported in homozygous and compound heterozygous individuals with ORAI1 deficiency and determined to be pathogenic (PMID: 26070885, 20004786, 27063589). This suggests that deletion of the C-terminal region of the ORAI1 protein is causative of disease. In summary, this is a novel insertion that leads to the disruption of most of the ORAI1 protein sequence, and truncating variants downstream from this variant have been shown to be deleterious. Therefore, it has been classified as Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at